Table 3 Distribution of oral mucosal diseases with HCV-related liver diseases
From: Analysis of the factors motivating HCV-infected patients to accept interferon therapy
No | Sex | Age | Liver disease | Oral lichen planus | Oral cancer | Oral leukoplakia | Aphthous stomatitis | Xerostomia | Oral candidosis | Traumatic ulcer | Benign tumor | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(n = 11) | (n = 1) | (n = 1) | (n = 3) | (n = 3) | (n = 2) | (n = 1) | (n = 3) | |||||||||||
buccal mucosa | gingiva | tongue | lower lip | oral floor | soft palate | type | onset | tongue | tongue | tongue | ||||||||
1 | F | 55 | CH-C | ◯ | ◯ | erosive | during IFN therapy | |||||||||||
2 | F | 58 | CH-C | ◯ | ||||||||||||||
3 | M | 54 | CH-C | ◯ | ◯ | ◯ | ◯ | erosive | before IFN therapy | |||||||||
4 | M | 62 | CH-C | ◯ | ◯ | reticular | during IFN therapy | |||||||||||
5 | F | 66 | CH-C | ◯ | erosive | before IFN therapy | ||||||||||||
6 | M | 61 | CH-C | ◯ | ||||||||||||||
7 | F | 55 | CH-C | ◯ | reticular | during IFN therapy | ||||||||||||
8 | F | 62 | CH-C | ◯ (with fissured tongue) | ||||||||||||||
9 | F | 72 | CH-C | ◯ | erosive | before IFN therapy | ||||||||||||
10 | F | 70 | CH-C | ◯ (with fissured tongue) | ||||||||||||||
11 | M | 58 | CH-C | ◯ | ||||||||||||||
12 | F | 57 | CH-C | ◯ | ◯ | ◯ | erosive | before IFN therapy | ◯ (post ope.) | |||||||||
13 | F | 60 | CH-C | ◯ | ||||||||||||||
14 | F | 71 | LC-C | ◯ | erosive | before IFN therapy | ◯ | |||||||||||
15 | F | 66 | CH-C | ◯ | ||||||||||||||
16 | M | 67 | CH-C | ◯ | ||||||||||||||
17 | F | 66 | CH-C | ◯ | ||||||||||||||
18 | F | 64 | CH-C | ◯ | ◯ | erosive | before IFN therapy | |||||||||||
19 | F | 61 | CH-C | ◯ | reticular | before IFN therapy | ||||||||||||
20 | F | 29 | CH-C | ◯ | ||||||||||||||
21 | F | 67 | CH-C | ◯ | reticular | before IFN therapy | ||||||||||||
22 | F | 49 | CH-C | ◯ | ||||||||||||||
23 | M | 48 | CH-C | ◯ | ||||||||||||||